Contract Development Services

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

From geopolitical conflicts to cyber threats, CDMOs must rethink resilience.

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Milton Boyer and Dave Stevens delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Voting is now open for our 2025 Company of the Year Awards.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

Your API is about to graduate to clinical trial manufacturing. Now what?!